About Us

Bellicum is addressing the need for safer and more effective cell therapies to treat cancers and other life-threatening diseases. The Company’s cell therapies are designed to strengthen immune response, or eliminate transplanted cells when their mission is complete or they put a patient’s health at risk. We are advancing clinical programs in stem cell transplants, prostate cancer, CAR T cells to treat solid tumors, and non-malignant genetic diseases.